

HY-P99025 · 1 mg
MedChemExpress · Cat: HY-P99025
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/lebrikizumab.html
Description
Lebrikizumab TNX-650 is an IgG4 humanized anti-interleukin-13 IL-13 mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4R?/IL-13R?1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases.







